Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6. - Wikidata - wikimedia - TriplyDB

Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6.

Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6.

http://www.wikidata.org/entity/Q34241487

about

Direct effects of hepatitis C virus on the lymphoid cells Interleukin-27 is differentially associated with HIV viral load and CD4+ T cell counts in therapy-naïve HIV-mono-infected and HIV/HCV-co-infected Chinese HCV infection enhances Th17 commitment, which could affect the pathogenesis of autoimmune diseases.Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement Lymphotropic HCV strain can infect human primary naïve CD4+ cells and affect their proliferation and IFN-γ secretion activity.Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection.1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial.Dysfunction of Immune Systems and Host Genetic Factors in Hepatitis C Virus Infection with Persistent Normal ALT.Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2.Virologic and immunologic aspects of HIV-hepatitis C virus coinfection.Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase.Biological significance of HCV in various kinds of lymphoid cells.PD-L1+MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment.Sequential immunological analysis of HBV/HCV co-infected patients during Peg-IFN/RBV therapy.Eradication of hepatitis C virus could improve immunological status and pyoderma gangrenosum-like lesions.Authentic Patient-Derived Hepatitis C Virus Infects and Productively Replicates in Primary CD4+ and CD8+ T Lymphocytes In Vitro.Rapid reduction of hepatitis C virus-Core protein in the peripheral blood improve the immunological response in chronic hepatitis C patients.

P2860

Q26992142-AB718CE1-94BA-4B3B-A077-B45DEAC2972B Q33590441-12B49722-00BE-4AAE-B39D-D595903F1466 Q33721367-521D1EAB-2F24-4784-8878-A311971ADAF5 Q33883727-45A6796A-121D-4D54-8CA5-739B1E14DBC1 Q34342117-7BA4FD22-4684-4C20-A31B-5FDCA100D691 Q34648954-A8F1DE66-CD27-4A0F-94A8-D131A02B0496 Q34744383-91B1B79B-1482-44E7-98AC-81AD35A20051 Q35094287-D5D7EEB5-A388-404D-946E-9253971AB955 Q35563500-23006027-1014-4026-8C15-D5B34BBDB58D Q36244165-163AE212-0CDF-4150-B8D7-085FD0516FD1 Q38900456-04548A87-6373-4AFA-BBC2-6C6CBE3A20AE Q39672405-0F845500-17D8-42C0-99F7-ACA8EEF1AAF7 Q42086875-47869EA9-639E-4FE7-A962-7E4462E2BF3B Q42264428-D418FA5C-0757-4099-A194-417EC561C414 Q42980390-34087B4A-4CD0-4652-B13B-639309A0C210 Q43652474-301C47A8-2815-4811-A43C-BD6BFD601439 Q45324384-BD616165-C9BD-4869-B415-02813ECE83CB Q45362985-8E4006E4-2939-4FE2-AAFC-DE02BB2051B2

P2860

Hepatitis C virus infection of T cells inhibits proliferation and enhances fas-mediated apoptosis by down-regulating the expression of CD44 splicing variant 6.

http://www.wikidata.org/entity/Q34241487

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@ast

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@en

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@nl

type

label

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@ast

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@en

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@nl

prefLabel

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@ast

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@en

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@nl

P1433

Q34241487-C1AC282C-216B-4340-B3C6-8BECF963ADE9

P1476

Q34241487-67298CA0-1C43-4ED2-8749-523259D50F78

P2093

Q34241487-17FA31B5-3249-4286-930D-FC09F71AB6E5

Q34241487-605C0CEB-016E-4052-ADF7-B00078EFAFE0

Q34241487-6C1E8EC0-AFF7-4FDF-97A0-E52DD80AA27A

Q34241487-84D755B3-6583-41FD-BE7B-5CECCCCD1990

Q34241487-A625571A-CE0D-4111-A941-DF6433A22E06

Q34241487-BF54E5CE-BF46-4506-8A4F-94DC940132F1

Q34241487-EFB63C4F-A52B-444B-A453-08758F081F26

P2860

Q34241487-014FB544-D5E9-448D-A2C8-34F8822E66EC

Q34241487-029E093E-35B4-435C-9769-806F1B275B39

Q34241487-068D2D4A-3285-4374-A3D8-7815192B8395

Q34241487-09BED09F-5123-442E-9320-45D497F34AD0

Q34241487-0B0A416A-7CEB-49C7-AD34-99DCCA82545F

Q34241487-13EC0635-D556-4B6B-9DEA-A447F8B6A8FA

Q34241487-17B4208B-6E5A-4BA9-B543-FBF1D806FC4E

Q34241487-17F7B25C-D37D-48F6-8AF9-F9B7D088844A

Q34241487-1EA4226A-B733-4C1C-B0B6-C952325C1EBD

Q34241487-234F1D69-6A82-42F2-A2D2-D0A1895C1FDE

P304

Q34241487-6BBA5C52-F7B4-420D-AD86-E56956E74252

P31

Q34241487-24E23029-347C-441F-9670-93F0404F4A41

P356

Q34241487-DD7C7011-89B6-4BCB-9F38-B3FF1F164534

P407

Q34241487-3369B71E-A464-422A-99CF-3D1FA4B17484

P433

Q34241487-95F96426-1475-4A6B-AF98-C357A965F329

P478

Q34241487-B999089A-88E5-49BB-BB1C-3D2D25B4A3FC

P50

Q34241487-9A9E13DA-1981-4AE4-8C42-69266CF0F3EA

P577

Q34241487-D8068BC2-4CD2-4BA4-8D9A-D2234A607A34

P5875

Q34241487-D30C3DFE-514F-4A4E-83ED-52D3870E6D26

P698

Q34241487-BA1B1459-8806-4D98-B09B-E2CE2F3F9BA1

P932

Q34241487-084549A9-0F0E-45F7-AC4C-DB8CAE1ABD09

P356

P1433

The Journal of Infectious Diseases

P1476

Hepatitis C virus infection of ...... on of CD44 splicing variant 6.

@en

P2093

Helene Minyi Liu

http://www.w3.org/2001/XMLSchema#string

Keigo Machida

http://www.w3.org/2001/XMLSchema#string

Koju Kobayashi

http://www.w3.org/2001/XMLSchema#string

Takaji Wakita

http://www.w3.org/2001/XMLSchema#string

Tooru Shimosegawa

http://www.w3.org/2001/XMLSchema#string

Yasuteru Kondo

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Ueno

http://www.w3.org/2001/XMLSchema#string

P2860

The SH3 binding motif of HCV [corrected] NS5A protein interacts with Bin1 and is important for apoptosis and infectivity

Robust hepatitis C virus infection in vitro.

Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6

Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.

Characterization of hepatitis C virus replication in cloned cells obtained from a human T-cell leukemia virus type 1-infected cell line, MT-2

Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein

Efficient initiation of HCV RNA replication in cell culture

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

Complete replication of hepatitis C virus in cell culture

P304

726-736

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/596739

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

199

http://www.w3.org/2001/XMLSchema#string

P50

Michael M. C. Lai

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23987047

http://www.w3.org/2001/XMLSchema#string

P698

19199548

http://www.w3.org/2001/XMLSchema#string

P932

4174598

http://www.w3.org/2001/XMLSchema#string